Back to Journals » Open Access Journal of Clinical Trials » Volume 6 » default

ESCI

SJR OA

CiteScore

Open Access Journal of Clinical Trials

ISSN: 1179-1519

Archive: Volume 6, 2014

Review

Pediatric clinical trials: a US perspective

Oelstrom MJ, Hoover-Regan ML

Open Access Journal of Clinical Trials 2014, 6:127-138

Published Date: 26 November 2014

Methodology

Randomized controlled trial to evaluate the effect of canola oil on blood vessel function in peripheral arterial disease: rationale and design of the Canola-PAD Study

Enns JE, Zahradka P, Guzman RP, Baldwin A, Foot B, Taylor CG

Open Access Journal of Clinical Trials 2014, 6:117-125

Published Date: 25 October 2014

Methodology

A gender-medicine post hoc analysis (MetaGeM) project to test sex differences in previous observational studies in different diseases: methodology

Colombo D, Bellia G, Vassellatti D, Zagni E, Sgarbi S, Rizzoli S

Open Access Journal of Clinical Trials 2014, 6:111-116

Published Date: 13 October 2014

Review

Clinical trial design in the era of comparative effectiveness research

Winter AC, Colditz GA

Open Access Journal of Clinical Trials 2014, 6:101-110

Published Date: 3 October 2014

Study Protocol

Randomized controlled trial of a positive affect intervention to reduce stress in people newly diagnosed with HIV; protocol and design for the IRISS study

Moskowitz JT, Carrico AW, Cohn MA, Duncan LG, Bussolari C, Layous K, Hult JR, Brousset A, Cotten P, Maurer S, Pietrucha ME, Acree M, Wrubel J, Johnson MO, Hecht FM, Folkman S

Open Access Journal of Clinical Trials 2014, 6:85-100

Published Date: 22 September 2014

Review

Evolution of the clinical trial landscape in Asia Pacific

Yathindranath S, Kureishi A, Singh S, Yeow S, Geng G, Wai K, Ho A, Lansang EZ, Lee KJ

Open Access Journal of Clinical Trials 2014, 6:75-84

Published Date: 29 July 2014

Methodology

Between- and within-patient n-level response surface pathway design in dose-finding studies

Dewi S, Kristiansen V, Lindkær-Jensen S, Larsen S

Open Access Journal of Clinical Trials 2014, 6:63-74

Published Date: 3 July 2014

Original Research

Safety and tolerability of an intravenously administered alpha1-proteinase inhibitor at an increased infusion rate: a novel, randomized, placebo-masked, infusion rate-controlled, crossover study in healthy adults

Ngo LY, Haeberle A, Dyck-Jones J, Gelmont D, Yel L

Open Access Journal of Clinical Trials 2014, 6:55-61

Published Date: 23 June 2014

Original Research

TRANSFORM: a novel study design to evaluate the effect of everolimus on long-term outcomes after kidney transplantation

Pascual J, Srinivas TR, Chadban S, Citterio F, Oppenheimer F, Tedesco H, Henry ML, Legendre C, Watarai Y, Sommerer C, Lee PC, Hexham JM, Dong G, Bernhardt P, Vincenti F

Open Access Journal of Clinical Trials 2014, 6:45-54

Published Date: 10 June 2014

Methodology

Study design and patient recruitment for the Japan Polyp Study

Sano Y, Fujii T, Matsuda T, Oda Y, Kudo S, Igarashi M, Iishi H, Kaneko K, Hotta K, Kobayashi N, Yamaguchi Y, Kobayashi K, Ishikawa H, Murakami Y, Shimoda T, Fujimori T, Ajioka Y, Taniguchi H, Ikematsu H, Konishi K, Saito Y, Yoshida S

Open Access Journal of Clinical Trials 2014, 6:37-44

Published Date: 21 May 2014

Original Research